Health-related quality of life outcomes in HIV-infected patients starting different combination regimens in a randomized multinational trial: The INITIO-QoL substudy

AIDS Research and Human Retroviruses

Volumn 23, Issue 10, 2007, Pages 1215-1222

  Bucciardini, Raffaella ^a   Fragola, Vincenzo ^a   Massella, Maurizio ^a   Polizzi, Cosimo ^a   Mirra, Marco ^a   Goodall, Ruth ^b   Carey, Dianne ^c   Hudson, Fleur ^b   Zajdenverg, Roberto ^d   Floridia, Marco ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; EFAVIRENZ; NELFINAVIR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE;

ADULT; ARTICLE; AUSTRALIA AND NEW ZEALAND; BRAZIL; CANADA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INITIO; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL OUTCOMES STUDY HUMAN IMMUNODEFICIENCY VIRUS QUESTIONNAIRE; MENTAL HEALTH SUMMARY; METHODOLOGY; OUTCOME ASSESSMENT; PHYSICAL HEALTH SUMMARY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; UNITED KINGDOM;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CLINICAL PROTOCOLS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; PHYSICAL FITNESS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 35549005466     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0067     Document Type: Article

References (15)

1. http://www.fda.gov/fdac/features/2006/606_patients.html.
2. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents: Available at http://www.aidsinfo.nih.gov/. Accessed April 15, 2007.
3. INITIO Trial International Co-ordinating Committee: Virological and immunological outcome at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: Open-label randomised trial. Lancet 2006;368:287-298.
4. Wu AW, Rubin HR, Matheus WC, et al.: A health status questionnaire using 30 items from the Medical Outcomes Study: Preliminary validation in person with early HIV infection. Med Care 1991;29:786-798.
5. Wu AW, Hays RD, Kelly S, Malitz F, and Bozzette SA: Application of Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Qual Life Res 1997;6:531-554.
6. Wu AW, Revicki DA, Jacobson D, and Malitz FE: Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res 1997;6:481-493.
7. Murri R, Ammassari A, Fantoni M, et al.: Disease-related factors associated with health-related quality of life in people with non-advanced HIV disease assessed using an Italian version of the MOS-HIV Health Survey. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:350-356.
8. Casado A, Badia X, Consiglio E, et al.: Health-related quality of life in HIV-infected naive patients treated with nelfinavir or nevirapine associated with ZDV/3TC (the COMBINE-QoL substudy). HIV Clin Trials 2004;5:132-139.
9. van Leth F, Conway B, Laplume H, Martin D, Fisher M, Jelaska A, Wit FW, Lange JM; 2NN study group: Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine and/or efavirenz. Antiviral Ther 2004;9:721-728.
10. Nieuwkerk PT, Gisolf EH, Reijers MH, Lange JM, Danner SA, Sprangers MA; NATIVE Study Group; PROMETHEUS Study Group; ADAM Study Group: Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. AIDS 2001;15:1985-1991.
11. Lorenz KA, Shapiro MF, Asch SM, Bozzette SA, and Hays RD: Associations of symptoms and health-related quality of life: Findings from a national study of persons with HIV infection. Ann Intern Med 2001;134:854-860.
12. Cunningham WE, Shapiro MF, Hays RD, Dixon WJ, Visscher BR, George WL, Ettl MK, and Beck CK: Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease. Am J Med 1998;104:129-136.
13. Mathews WC, McCutchan JA, Asch S, Turner BJ, Gifford AL, Kuromiya K, Brown J, Shapiro MF, and Bozzette SA: National estimates of HIV-related symptom prevalence from the HIV Cost and Services Utilization Study. Med Care 2000;38:750-762.
14. Justice AC, Rabeneck L, Hays RD, Wu AW, and Bozzette SA: Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: A comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group. J Acquir Immune Defic Syndr 1999;21:126-133.
15. Lorenz KA, Cunningham WE, Spritzer KL, and Hays RD: Changes in symptoms and health-related quality of life in a nationally representative sample of adults in treatment for HIV. Qual Life Res 2006;15:951-958.